A. No. The FDA believes that scientifically legitimate analysis conducted under an IND application will be the best way to ascertain what patients could reap the benefits of the usage of medicines derived from cannabis. The FDA supports the carry out of that exploration by: Existing exploration originates from https://aneurinl135qrs9.wikijournalist.com/user